Transition From Research to Disclosure in Human Genetics
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this study is to design a means of providing research families, from diverse geographical locations, the chance to receive genetic testing after having been educated by video, and meetings or telephone conversations with a genetic counselor/study professional.
| Condition | Intervention |
|---|---|
|
Education |
Behavioral: Genetic Counseling |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Transition From Research to Disclosure in Human Genetics |
- Number of Participants Received Pre-test Genetic Counseling [ Time Frame: 10 Years ] [ Designated as safety issue: No ]
- Number of participants completing genetic testing for p53 [ Time Frame: Baseline to time of follow-up (2 weeks, 6, and 12 months) ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
After receiving pre-test genetic counseling, participants will be given the opportunity to schedule a submission of a small sample of blood (about 6 tablespoons) for genetic testing for p53.
| Estimated Enrollment: | 800 |
| Study Start Date: | May 1999 |
| Estimated Primary Completion Date: | May 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Pre-Test Genetic Counseling + Genetic Sample |
Behavioral: Genetic Counseling
Genetic counseling conducted in person, by telephone with an M. D. Anderson Genetic Counselor, or with a local Genetic Counselor in conference with the M. D. Anderson Genetic Counselor.
|
Detailed Description:
Participants will receive pre-test genetic counseling in one of three ways: (1) in person at MD Anderson; (2) by telephone with an MD Anderson Genetic Counselor/study professional; (3) with a local Genetic Counselor in conference with the MD Anderson Genetic Counselor/study professional. After receiving pre-test genetic counseling, participants will be given the opportunity to schedule a submission of a small sample of blood (about 6 tablespoons) for genetic testing for p53.
Participants who submit a sample will be required to see a genetic counselor/study professional to receive the results of the genetic test. Genetic counseling may take place at MD Anderson at no cost. Participants may wish to have counseling close to their home, though they then are responsible for the cost of the counseling. If, after talking to the counselor/study professional, the participant wants to know the results of the test, he or she will be told. A participant will be given more counseling and advice on what other care might be needed and what other actions they should take.
If you have a child under the age of 27, you will fill out survey that will ask about how you would feel about your child taking part in genetic testing. This survey will take about 15-20 minutes to complete.
You will either fill out this survey over the telephone or it will be mailed to you. If it is by mail, you will be given a self-addressed stamped envelope to send the survey back to the study staff.
Participants who decide to know the test results will schedule a telephone conversation with the genetic counselor/study professional within 2-3 months. This will include more counseling, with additional follow-up as needed.
The test results and the survey will be kept private. Names will not be used in computer records.
This is an investigational study. About 800 people will be offered genetic testing. This study is being performed only at MD Anderson.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Patient diagnosed with cancer or a participant with a family member who has had cancer.
Inclusion Criteria:
- Members of families who have participated in the p53 project through Dr. Strong's lab are eligible, via protocol P90-001. There are at least 115 kindreds including at least 800 participants living who may be at risk of carrying a p53 germline mutation.
- The participants must provide an informed consent and be 18 years or older.
- We will include English and non-English speaking participants. For non-English speaking participants to be recruited, the consent documents has been translated into the language of the target population in accordance with the IRB procedures.
For the survey portion of this study, we will invite individuals who:
- are already enrolled in the present study (protocol BS99-038),
- are at risk for carrying a p53 mutation, and
- have children who are less than 27 years old. -Patients who agree to enroll in the survey portion of the study will sign a specific informed consent form (Transition from Research to Disclosure in Human Genetics, BS99-038, Subtitle: Optional Survey). The informed consent document for the survey portion of the study will be translated into the language of the target population for non-English speaking participants in accordance with the IRB procedures.
Exclusion Criteria:
N/A
Contacts and Locations| Contact: Louise C. Strong, MD | 713-792-7555 |
| United States, Texas | |
| U.T.M.D. Anderson Cancer Center | Recruiting |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: Louise C. Strong, MD | |
| Principal Investigator: | Louise C. Strong, MD | M.D. Anderson Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00505466 History of Changes |
| Other Study ID Numbers: | BS99-038 |
| Study First Received: | July 19, 2007 |
| Last Updated: | February 26, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by M.D. Anderson Cancer Center:
|
Human Genetics Genetic Counseling Genetic Testing p53 Mutation Genetics |
ClinicalTrials.gov processed this record on May 19, 2013